TGFB1 and systemic sclerosis: Other regulatory pathways of TGF-β effects involve various non-receptor tyrosine kinases (167, 168), including the cytoplasmic Abelson kinase (c-Abl) and protein kinase C-δ (PKC-δ), to contribute to the fibrosis and vasculopathy of the skin and internal organs in SSc.